Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,454.80
+1.00 (0.07%)
At close: Aug 14, 2025, 3:30 PM IST
Emcure Pharmaceuticals Company Description
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular.
It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names.
Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Emcure Pharmaceuticals Limited
| Country | India |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,731 |
| CEO | Satish Mehta |
Contact Details
Address: Plot No. P-1 and P-2 Pune, Maharashtra 411057 India | |
| Phone | 91 20 3507 0033 |
| Website | emcure.com |
Stock Details
| Ticker Symbol | EMCURE |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE168P01015 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Sanjay Singh | Chief Executive Officer of Gennova Biopharmaceuticals Limited |
| Satish Ramanlal Mehta | Chief Executive Officer, MD and Executive Director |
| Chetan Rajendra Sharma | Company Secretary and Compliance Officer |
| Naveen Soni | Director of Corporate Communications and Public Relations |
| Vikas Madan Thapar | President of Corporate Development, Strategy and Finance |
| Rajesh Nair | President of Human Resources |
| Sanjay Rajanikant Mehta | President of Emerging Markets |
| Deepak Gondaliya | President of Technical Operations |
| Kuber Mahadeo Jagdale | President of API business |
| R.S. Vasan | President of India Business |